Last 12 months
Inside the activity.
0 purchase rows · 202 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 39 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 42 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 10 |
| Jun 2026 | 0 | 18 |
| Jul 2026 | 0 | 20 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2024 Filed Feb 16, 2024 22:00 UTC |
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
|
GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004163 · form4-02162024_050204.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,528 F1 · shares: Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:00 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 47,500 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004164 · form4-02162024_050209.xml · derivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires 2034-02-14 F4 · derivative.exercise_date: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:00 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
GrantCommon Stock | 870 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004164 · form4-02162024_050209.xml · nonDerivative · entry 3 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 4,576 F3 · shares: Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:00 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004164 · form4-02162024_050209.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,202 F2 · shares: Restricted stock units granted on February 15, 2024 that vest in two equal installments over two years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:00 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
GrantCommon Stock | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004164 · form4-02162024_050209.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,202 F1 · shares: Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:00 UTC |
Pauwels EricCHIEF BUSINESS OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004162 · form4-02162024_050202.xml · derivative · entry 3 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2034-02-14 F3 · derivative.exercise_date: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:00 UTC |
Pauwels EricCHIEF BUSINESS OFFICER
|
GrantCommon Stock | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004162 · form4-02162024_050202.xml · nonDerivative · entry 2 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,481 F2 · shares: Restricted stock units granted on February 15, 2024 that vest in two equal installments over two years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:00 UTC |
Pauwels EricCHIEF BUSINESS OFFICER
|
GrantCommon Stock | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004162 · form4-02162024_050202.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,181 F1 · shares: Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:25 UTC |
SCHMERTZLER MICHAELDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004133 · form4-02162024_040204.xml · derivative · entry 2 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:25 UTC |
SCHMERTZLER MICHAELDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004133 · form4-02162024_040204.xml · nonDerivative · entry 1 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,266 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:20 UTC |
Bell William F. Jr.Director
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004122 · form4-02162024_040204.xml · derivative · entry 2 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:20 UTC |
Bell William F. Jr.Director
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004122 · form4-02162024_040204.xml · nonDerivative · entry 1 Bell William F. Jr. · CIK 0001980122 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,333 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:20 UTC |
SOUTHWELL DAVID PDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004121 · form4-02162024_040201.xml · derivative · entry 2 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:20 UTC |
SOUTHWELL DAVID PDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004121 · form4-02162024_040201.xml · nonDerivative · entry 1 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:16 UTC |
Okey StephanieDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004116 · form4-02162024_090223.xml · derivative · entry 2 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:16 UTC |
Okey StephanieDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004116 · form4-02162024_090223.xml · nonDerivative · entry 1 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,867 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:11 UTC |
Gravier PierreCHIEF FINANCIAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 47,500 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004108 · form4-02162024_040248.xml · derivative · entry 3 Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires 2034-02-14 F3 · derivative.exercise_date: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:11 UTC |
Gravier PierreCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 3,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004108 · form4-02162024_040248.xml · nonDerivative · entry 2 Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,800 F2 · shares: Restricted stock units granted on February 15, 2024 that vest in two equal installments over two years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:11 UTC |
Gravier PierreCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004108 · form4-02162024_040248.xml · nonDerivative · entry 1 Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,700 F1 · shares: Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Golden Lee ScottCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004107 · form4-02162024_040242.xml · derivative · entry 3 Golden Lee Scott · CIK 0001686217 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-02-14 F3 · derivative.exercise_date: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Golden Lee ScottCHIEF MEDICAL OFFICER
|
GrantCommon Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004107 · form4-02162024_040242.xml · nonDerivative · entry 2 Golden Lee Scott · CIK 0001686217 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,514 F2 · shares: Restricted stock units granted on February 15, 2024 that vest in two equal installments over two years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Golden Lee ScottCHIEF MEDICAL OFFICER
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004107 · form4-02162024_040242.xml · nonDerivative · entry 1 Golden Lee Scott · CIK 0001686217 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,914 F1 · shares: Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004106 · form4-02162024_040237.xml · derivative · entry 2 Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004106 · form4-02162024_040237.xml · nonDerivative · entry 1 Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,475 F1 · shares: Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004104 · form4-02162024_040235.xml · derivative · entry 3 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2034-02-14 F3 · derivative.exercise_date: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
GrantCommon Stock | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004104 · form4-02162024_040235.xml · nonDerivative · entry 2 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,389 F2 · shares: Restricted stock units granted on February 15, 2024 that vest in two equal installments over two years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
GrantCommon Stock | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004104 · form4-02162024_040235.xml · nonDerivative · entry 1 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,189 F1 · shares: Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Reeve EmmaDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004100 · form4-02162024_040209.xml · derivative · entry 2 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-15 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Reeve EmmaDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004100 · form4-02162024_040209.xml · nonDerivative · entry 1 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,200 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Jacobson Allan StevenDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004103 · form4-02162024_040229.xml · derivative · entry 2 Jacobson Allan Steven · CIK 0001579003 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Jacobson Allan StevenDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004103 · form4-02162024_040229.xml · nonDerivative · entry 1 Jacobson Allan Steven · CIK 0001579003 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,348 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
ZELDIS JEROME BDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004102 · form4-02162024_040221.xml · derivative · entry 2 ZELDIS JEROME B · CIK 0001433982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
ZELDIS JEROME BDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004102 · form4-02162024_040221.xml · nonDerivative · entry 1 ZELDIS JEROME B · CIK 0001433982 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (i) four years from the date of grant and (ii) the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Young AlethiaDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004101 · form4-02162024_040218.xml · derivative · entry 2 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Young AlethiaDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004101 · form4-02162024_040218.xml · nonDerivative · entry 1 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,067 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
STEELE GLENN JR MD PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004099 · form4-02162024_040203.xml · derivative · entry 2 STEELE GLENN JR MD PHD · CIK 0001269131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
STEELE GLENN JR MD PHDDirector
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004099 · form4-02162024_040203.xml · nonDerivative · entry 1 STEELE GLENN JR MD PHD · CIK 0001269131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,500 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (i) four years from the date of grant and (ii) the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Smith Mary L.Director
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $25.69 | $0.00 |
DisclosureSEC source: 0001415889-24-004098 · form4-02162024_040201.xml · derivative · entry 2 Smith Mary L. · CIK 0001866044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-02-14 F2 · derivative.exercise_date: This option was granted on February 15, 2024 and vests over one year in twelve equal monthly installments, commencing on March 15, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:10 UTC |
Smith Mary L.Director
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004098 · form4-02162024_040201.xml · nonDerivative · entry 1 Smith Mary L. · CIK 0001866044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,813 F1 · shares: Restricted stock units granted on February 15, 2024 that vest over one year, with one-third (1/3) of the shares underlying the RSUs vesting on June 18, 2024 and the remaining two-thirds (2/3) of the original shares underlying the RSUs vesting on February 15, 2025. Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:18 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
SaleCommon Stock | 28 | $27.25 | $763.02 |
DisclosureSEC source: 0001415889-24-002174 · form4-02012024_090242.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 3,706 F2 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 93 RSUs from a January 29, 2020 grant of 370 RSUs. Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:18 UTC |
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
|
SaleCommon Stock | 618 | $27.25 | $16,840.99 |
DisclosureSEC source: 0001415889-24-002174 · form4-02012024_090242.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,202 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 29, 2020 grant of 10,200 RSUs. Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:17 UTC |
Boulding Mark ElliottEXEC. VP AND CLO
|
SaleCommon Stock | 794 | $27.25 | $21,637.14 |
DisclosureSEC source: 0001415889-24-002173 · form4-02012024_090230.xml · nonDerivative · entry 1 Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,189 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 29, 2020 grant of 10,200 RSUs. Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:16 UTC |
Pauwels EricCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 366 | $27.25 | $9,973.79 |
DisclosureSEC source: 0001415889-24-002171 · form4-02012024_090228.xml · nonDerivative · entry 1 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,181 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 1,198 RSUs from a January 29, 2020 grant of 4,790 RSUs. Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:15 UTC |
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
|
SaleCommon Stock | 318 | $27.25 | $8,665.75 |
DisclosureSEC source: 0001415889-24-002169 · form4-02012024_090204.xml · nonDerivative · entry 1 Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,528 F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 1,020 RSUs from a January 29, 2020 grant of 4,080 RSUs. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 21:30 UTC |
Jacobson Allan StevenDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $27.05 Strike: $27.05 | $270,500.00 |
DisclosureSEC source: 0001415889-24-001753 · form4-01242024_090138.xml · derivative · entry 3 Jacobson Allan Steven · CIK 0001579003 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F3 · derivative.exercise_date: Currently exercisable. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 21:30 UTC |
Jacobson Allan StevenDirector
|
SaleCommon Stock | 10,000 | $27.38 | $273,804.00 |
DisclosureSEC source: 0001415889-24-001753 · form4-01242024_090138.xml · nonDerivative · entry 2 Jacobson Allan Steven · CIK 0001579003 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,348 F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $27.15 to $27.90 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 21:30 UTC |
Jacobson Allan StevenDirector
|
Exercise / conversionCommon Stock | 10,000 | $27.05 | $270,500.00 |
DisclosureSEC source: 0001415889-24-001753 · form4-01242024_090138.xml · nonDerivative · entry 1 Jacobson Allan Steven · CIK 0001579003 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 21:11 UTC |
Utter Christine MarieSVP, FINANCE & CAO
|
SaleCommon Stock | 1,653 | $29.01 | $47,961.46 |
DisclosureSEC source: 0001415889-24-000921 · form4-01102024_090117.xml · nonDerivative · entry 2 Utter Christine Marie · CIK 0001707685 · SVP, FINANCE & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,846 F3 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,175 RSUs from a January 6, 2021 grant of 8,700 RSUs and the vesting of 2,900 RSUs from a January 7, 2022 grant of 11,600 RSUs. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 21:09 UTC |
Pauwels EricCHIEF BUSINESS OFFICER
|
SaleCommon Stock | 2,065 | $29.01 | $59,915.56 |
DisclosureSEC source: 0001415889-24-000917 · form4-01102024_090157.xml · nonDerivative · entry 2 Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,547 F3 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs and the vesting of 4,200 RSUs from a January 7, 2022 grant of 16,800 RSUs Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 21:08 UTC |
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 5,443 | $29.01 | $157,927.56 |
DisclosureSEC source: 0001415889-24-000915 · form4-01102024_090152.xml · nonDerivative · entry 2 Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 160,475 F2 · shares: Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,250 RSUs from a January 6, 2021 grant of 9,000 RSUs and the vesting of 15,250 RSUs from January 7, 2022 grants totaling 41,000 RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.